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Background: Current tendon repair techniques do not provide sufficient tensile strength at the repair site, and thus
early active motion rehabilitation after tendon repair is discouraged. To enhance the post-operative tensile strength,
we proposed and tested an internal fixation technique using a polycaprolactone (PCL) biofilm. PCL was chosen for
its good biocompatibility, excellent mechanical strength, and an appropriate degradation time scale.
Methods: PCL biofilms were prepared by a modified melt-molding/leaching technique, and the physical and
mechanical properties and in vitro degradation rate were assessed. The pore size distribution of the biofilm and the
paratenon of native tendons were observed using scanning electron microscopy. Next, we determined whether this
biofilm could enhance the tensile strength of repaired tendons. We performed tensile tests on rabbit Achilles
tendons that were first lacerated and then repaired: 1) using modified Kessler suture combined with running
peripheral suture (‘control’ group), or 2) using biofilm to wrap the tendon and then fixation with sutures (‘biofilm’
group). The influence of different repair techniques on tendon tensile strength was evaluated by mechanical
testing.
Results: The novel biofilm had supple texture and a smooth surface. The mean thickness of the biofilm was
0.25 mm. The mean porosity of the biofilm was 45.3%. The paratenon of the rabbit Achilles tendon had pores with
diameters ranging from 1 to 9 μm, which were similar to the 4–12 μm diameter pores in the biofilm cross-section.
The weight loss of the biofilms at 4 weeks was only 0.07%. The molecular weight of PCL biofilms did not change
after immersion in phosphate buffered saline for 4 weeks. The failure loads of the biofilm were similar before (48 ±
9 N) and after immersion (47 ± 7 N, P > 0.1). The biofilm group had ~70% higher mean failure loads and 93% higher
stiffness compared with the control group.
Conclusions: We proposed and tested an internal fixation technique using a PCL biofilm to enhance tendon repair.
Internal fixation with the biofilm followed by standard suturing can significantly increase the tensile strength of
tendon repair sites. This technique has the potential to allow active motion rehabilitation during the early post-
operative period.
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Tendon injuries are common and surgical repair is often
necessary. During the healing process, the most com-
mon complication is adhesion formation, which restricts
tendon gliding. Historically, repaired flexor tendons were
immobilized (fixed in place with an external brace dur-
ing the first few post-operative weeks) until sufficient
healing had occurred to allow motion of the tendon [1].
Thus, adhesion formation inevitably occurred and led to
finger dysfunction. During surgical repair, avoidance of
tendon trauma and preservation of the anatomic integ-
rity of normally contiguous structures may decrease the
adhesion formation [2,3]. Since about the 1970s,
methods of mobilizing repaired tendons have been de-
veloped allowing limited passive motion to promote
gliding of the tendon during the post-operative period
[4-6]. Early passive mobilization might improve tendon
healing and enhance tendon gliding and tensile strength
at the repair site [7-11], but may also cause the tendon
to buckle, roll, or fold up [12]. Over the last three de-
cades, controlled active motion immediately after repair
was proposed and tested [13,14]. Controlled active mo-
tion protocols with conventional suture can produce a
high percentage of excellent and good outcomes [15,16].
However, because of the difficulties in controlling the
amount of load across the repair site during active mo-
tion rehabilitation, this technique is also associated with
a high rupture rate [17-19].
The optimal tendon repair technique would not only
provide coaptation without gap formation at the repair
site, but would also provide sufficient strength to safely
allow active mobilization to reduce adhesion formation
[20]. Immediate active mobilization of repaired tendons
was thought to be the most effective way to restore
function, and could decrease or even eliminate adhe-
sions [21-24]. However, in the early period after surgery,
the strength of the repair depended completely on the
repair materials and suture techniques.
Currently, popular techniques for tendon repair (e.g.
the modified Kessler suture plus running peripheral su-
ture) [25-29] do not provide sufficient tensile strength at
the repair site to recommend early active mobilization.
We hypothesized that wrapping a polycaprolactone
(PCL) biofilm around the repair site and fixing it in
place would increase the tensile strength of the repaired
tendon, creating a stable repair site for post-operative
early active mobilization.
PCL was chosen as the material for the internal fix-
ation biofilm because PCL is a non-toxic biodegradable
polyester, has a slow degradation rate, and demonstrates
excellent mechanical strength and biocompatibility
[30-36]. In this study, we examined the material proper-
ties of the PCL biofilm to determine whether it could be
used to strengthen tendon repairs.Methods
Experimental design
Biofilms were prepared using PCL, and the thickness,
porosity, pore size, and in vitro degradation rate were
measured. Three aspects of biofilm degradation were in-
vestigated: the weight, the molecular weight, and the
failure load after 4 weeks in solution.
To assess the ability of the PCL biofilm to enhance the
tensile strength of repaired tendons, we used a paired
group design for tensile testing of repaired rabbit Achil-
les tendons. One group was repaired using standard re-
pair techniques (‘control’ group), while the second group
was repaired using the PCL biofilm to wrap and fix the
repair site (‘biofilm’ group). Twelve animals in total were
used, with two operated digits per animal – one each for
the control and biofilm groups. In a second group of 12
animals, the paratenon of one tendon per animal (12
tendons in total) were stripped and used for observation
of the pore size distribution of the tendon outer mem-
brane. A flowchart summarizing the experimental design
is shown in Figure 1. The animal protocol used in the
current study was approved by the ethics review com-
mittee of the Third Xiangya Hospital, Central South
University.Biofilm specimen preparation
All chemicals were purchased from Alfa Aesar unless
otherwise specified. PCL (molecular weight: 200,000 Da)
was purchased from Yisheng New Materials Co., Ltd.,
Shenzhen, China. Before use, tetrahydrofuran (THF) and
N,N-dimethylformamide (DMF) were purified to remove
water. Briefly, THF was put in calcium hydride for reflux
for 12 h and redistilled, and DMF was stirred in calcium
hydride (5% w/v) for 12 h, filtered and then distilled at
20 mmHg. A modified melt-molding/leaching technique
was used to prepare the biofilms, using DMF as the
porogen. The blending of PCL, THF, and DMF was car-
ried out in a beaker on a magnetic stirrer (HPC07SA-P,
APLUS, Union city, CA, USA) operating at 45°C and a
stirring speed of 200 rpm. PCL (2 g) was added to 20 ml
of THF and mixed for 15 min to prepare a homogeneous
solution. Next, 1.7 ml of DMF was added and the solu-
tion mixed for another 5 min. The resulting blended so-
lution was placed into a rectangular mold of dimension
140 × 100 × 10 mm, and dried at 25°C until the THF had
completely evaporated. To obtain the biofilm, the shaped
PCL-DMF blends were immersed in a continuous shak-
ing deionized water bath at 37°C to leach out the DMF.
Fresh changes of deionized water were performed every
12 h until the wet specimen reached a constant weight,
confirming that all the DMF was removed. Finally, the
specimen was lyophilized for 24 h and stored in a dry
container until use.
Figure 1 A flowchart of the experimental design. (A) Biofilm specimen preparation and in vitro evaluation. (B) Animals used, tendons
harvested, experimental groups, and outcome measures.
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biofilm
The porosity of the specimen was measured by Archi-
medes’ method. First, the specimen was lyophilized to
determine the dry weight (W1). Then, the specimen was
transferred to a beaker and placed in a vacuum oven at
2 kPa for 15 min, followed by slow injection with water
until the specimen was completely immersed. Next, the
pressure was gradually restored to atmospheric, and
then the saturated specimen was placed in a copper wire
basket, suspended in a beaker filled with water, and
weighed (W2). The specimen was taken out of the water,
any water remaining on its surface was removed with
wet gauze, and the specimen was weighed again (W3).
The porosity was calculated using the following formula:
porosity (%) = [(W3 – W1)/(W3 – W2)] × 100% (n = 12).
Thickness was measured using a micrometer (n = 12).
In vitro degradation of the biofilm
The biofilm was cut into 100 mm × 20 mm pieces for
in vitro degradation testing. Lyophilized specimens were
accurately weighed (W0), and then immersed in phosphate
buffered saline (PBS) pH 7.4 in a continuous shaking
water bath at 37°C for 4 weeks. The degradation medium
of PBS was changed each week. After 4 weeks, the spec-
imens were removed, washed with deionized water, ly-
ophilized, and reweighed (WF). The percent weight loss
was calculated as: weight loss % = [(W0 −WF)/W0] ×
100% (n = 12). After 4 weeks of degradation, PCL
biofilms were dissolved in THF at a concentration of1 mg/mL and filtered through a 0.2-μm inorganic mem-
brane filter (GE Healthcare, UK). The molecular weight
of the biofilm was determined by gel permeation chro-
matography (GPC apparatus 1525, Waters Co., Milford,
MA, USA) (n = 12).
In order to examine the tensile strength, the speci-
mens were fixed in custom-made clamps and mounted
in a microcomputer-controlled electronic universal
mechanical testing machine (Dual Column Testing Sys-
tem 3369, Instron Co., Norwood, MA, USA). Before
testing, both the ends (10 mm) of the specimen were
first wrapped with tape and then clipped in the clamps
equipped with rubber pads. The initial distance between
the fixtures was set at 80 mm. The specimens were dis-
tracted at a rate of 5 mm/min until failure. During the
testing, if the specimen slipped away from the clamps,
or fracture occurred within 10 mm of any clamp, the
measurement was considered invalid. Throughout the
testing process, fracture occurred in the middle of all
specimens and no specimen slipped away from the
clamps.
Microstructural characterization of the biofilm and the
Achilles tendon outer membrane
Twelve rabbits were euthanized and 1 Achilles tendon
was harvested from each. The peeled paratenon of the
Achilles tendons were fixed with 2.5% glutaraldehyde,
dehydrated by alcohol gradients, soaked in osmium tet-
roxide, dried and coated with gold, and then the pore
size distribution of the tendon outer membrane was
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copy (FESEM, Nova NanoSEM 230, FEI Co., Hillsboro,
OR, USA) (n = 12). The prepared biofilms were placed
in liquid nitrogen for 30 min, broken to pieces, freeze-
dried, and evenly sprayed with gold. Finally, the cross-
section was observed with FESEM (n = 12).
Establishment of an in vitro model of Achilles tendon
repair
Twelve more rabbits were euthanized and 24 Achilles ten-
dons were harvested, two from each animal (length = 4 cm).
The Achilles tendons were sharply cut into two parts
(2 cm long each). For the control group, each tendon re-
pair was conducted using the modified Kessler method
(Figure 2A) with 4–0 polyester suture (DemeTECH,
Miami, FL, USA) and the running peripheral suture
(Figure 2B) with 6–0 polyester suture (DemeTECH).Figure 2 Schematic of tendon repair techniques. (A) Modified Kessler s
buried knot with three throws. (B) Running peripheral suture: 6–0 polyeste
tendon: after repairing with standard techniques, the Achilles tendon was w
the lacerated site. (D) Biofilm fixation: 6–0 polyester suture placed in a runn
superficial peripheral suture technique. Here, the needle passage was throu
a suture site for biofilm fixation after wrapping: using the running superfici
needle passage was through the biofilm, the paratenon, and only the supeFor the biofilm group, the tendons were repaired with
standard repair techniques, wrapped with PCL biofilm
(Figure 2C), and then sutured with 6–0 polyester su-
ture (Figure 2D). For the running superficial peripheral
suture, the needle passage was through the paratenon
and only the superficial tendon (Figure 2E). For fix-
ation of the biofilm, the needle passage was through
the biofilm, the paratenon, and only the superficial
tendon (Figure 2F).
Biomechanical testing of the tendon repair model
The repaired tendons were fixed in the universal mech-
anical testing machine clamps and distracted at a rate of
0.3 mm/min (n = 12). The length of tendon between the
clamps was kept constant at 3 cm. The load–displace-
ment curves were simultaneously traced by the testing
machine computer. The failure load was defined as theuture: 4–0 polyester suture placed in the tendon and tied with a single
r suture placed in a running fashion. (C) Biofilm-wrapped Achilles
rapped with biofilm, with 5 mm lengths of biofilm on both sides of
ing fashion. (E) Cross-section of a laceration repaired by the running
gh the paratenon and only the superficial tendon. (F) Cross-section of
al suture technique, the biofilm was fixed on the Achilles tendon. The
rficial tendon.
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pair was calculated as the slope of the linear region of
the load–displacement curve. The entire testing process
was conducted at a room temperature of 25°C with 70%
relative humidity, and the specimens were kept moist
with saline spray.
Statistical analysis
All data obtained are presented as mean ± SD. One-way
ANOVA with paired t-tests were performed to detect
significant (P < 0.05) effects of the experimental
variables.
Results
The biofilm had excellent physical properties
The thickness of the biofilm was 0.25 ± 0.06 mm, and
the porosity was 45.3 ± 5%. The biofilm had supple tex-
ture and smooth surface (Figure 3), and was surgically
manageable and easily incorporated at the repair site.
The biofilm degraded slowly in vitro
The biofilm degradation rates and the influence of early
degradation on the mechanical properties of the biofilm
were observed in vitro. All specimens showed very slow
degradation rates after soaking for 4 weeks in PBS. The
weight loss of the biofilms was only 0.07 ± 0.005% after
4 weeks.
The molecular weight of the biofilm showed no
change from 200,000 Da after 4 weeks soaking in PBS
(data not shown). The failure loads of the biofilm were
similar before (48 ± 9 N) and after 4 weeks of degrad-
ation (47 ± 7 N, P > 0.1). These results were correlated
with the minimal weight loss.Figure 3 Image of biodegradable PCL film. The biofilm had a supple te
incorporated at the repair site.The pore size distribution of the PCL biofilm was similar
to that of the Achilles tendon paratenon
FESEM was used to examine the pore size distribution of
the tendon outer membrane and the biofilm. Representa-
tive FESEM images of the biofilm and the tendon outer
membrane display similar pore diameters (Figure 4).
An examination of twelve specimens (3 random images
for each specimen) showed that the pore size of the
rabbit Achilles tendon outer membrane had diameters
ranging from 1 to 9 μm. The pore size of the cross-
section of the biofilm had diameters ranging from 4 to
12 μm.
Internal fixation with the biofilm can significantly increase
tensile strength of the tendon repair site
The mean failure load of the control group was 23.5 ±
4.9 N, while that of the biofilm group was 39.6 ± 6.7 N
(P < 0.05), an increase of almost 70%. The mean stiffness
of the control group was 7.11 ± 1.9 N/mm, while that of
the biofilm group was 13.69 ± 5.8 N/mm (P < 0.05), an
increase of almost 93%.
Discussion
Many different repair methods have been explored with
the aim of enhancing the tensile strength of repaired
tendons [37-40]. For various reasons, however, these
methods are not widely used in clinics. For example,
Becker et al. [37] reported a technique involving bevel-
ing of the tendon ends and fine compressive suturing.
The drawback of this approach is that it causes shorten-
ing of the tendon ends. The double loop locking suture
technique reported by Lee [38] and the fish mouth anas-
tomosis method described by Pulvertaft [39] were able
to strengthen the repair; however, normal tendonxture and smooth surface, and was surgically manageable and easily
Figure 4 FESEM images of the tendon outer membrane and biofilm cross-section. (A) The pores of rabbit Achilles tendon outer membrane
had diameters from 1 to 9 μm. (B) The pores of the cross-section of the biofilm had diameters from 4 to 12 μm. Three randomly chosen fields of
view were photographed from each specimen. Representative images are shown.
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stitch plus mesh sleeve technique described by
Silfverskiöld [40] is time-consuming and technically
complicated.
Currently, the modified Kessler suture plus running
peripheral suture is the most popular tendon repair
technique [28]. However, this suture technique cannot
develop enough strength at the suture site, and early ac-
tive motion may result in a higher incidence of rupture.
Therefore, new materials and techniques for increasing
the strength of tendon repair sites are needed for hand
surgery.This study presented a biofilm for internal fixation
that increased the failure load of in vitro tendon repair
by 70% over standard techniques, and, therefore, might
allow for the initiation of early active motion
rehabilitation.
PCL was chosen because of its desirable material prop-
erties, such as good biocompatibility and complete deg-
radation, absorption, and excretion in the body
[32,35,36,41,42]. In a previous study, rat mesenchymal
stem cells were able to adhere and proliferate on PCL
scaffolds for bone tissue engineering, demonstrating
good biocompatibility [32]. In a different study where
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implanted in rats, 92% of the implanted radioactive tracer
was excreted from feces and urine by 135 days after im-
plantation [30]. Finally, another study showed that three-
dimensional PCL scaffolds (Mn 80,000) had no molecular
weight change after 6 months in vitro and in vivo, reveal-
ing excellent long-term biocompatibility and no adverse
host tissue reactions [35]. Very little in vitro degradation
of the PCL film prepared (Mw 200,000) in the current
study was observed after 4 weeks. Therefore, the biofilm
would not lose its mechanical properties and would be
able to support the injured tendon repair during the early
stage of tendon healing. In addition, the high porosity of
the biofilms and the size of the pores were similar to
those of native tendons, suggesting that the biofilm
should not impede tendon nourishment.
While this study indicated that internal fixation with PCL
might enhance the strength of the repair after tendon injury
and repair, the present research was only an in vitro investi-
gation. Additional in vivo factors involved in tendon healing
could be investigated, such as potentially inhibitory effects
of wrapping a biofilm around the repair site on the migra-
tion of immune cells and fibroblasts to the site. Neutrophils
and monocytes infiltrate the repair during the first 3 post-
operative days. They play an important role in the clearance
of bacteria and debris and are vital for chemotaxis of fibro-
blasts to the repair site [43-45]. Fibroblasts are the cell type
that will eventually rebuild the tendon via the production
of collagen [43-45]. Many studies have shown that immune
cells and fibroblasts enter the repair site via the surface of
the tendon [43-47]. While the pore size of the PCL biofilm
is large enough for nutrients and cytokines to infiltrate,
it appears to be too small for many of these cell types
to gain access to the repair site. Neutrophils are generally
12–15 μm, monocytes are 10–30 μm, and tendon fibro-
blasts are 20–70 μm in length and 8–20 μm wide. Given
that the pores of the biofilm are only 4–12 μm, it appears
that the biofilm would inhibit cell infiltration, and thus im-
pede tendon healing. However, many methods could be
adopted to enlarge the pore size, such as increasing the
DMF concentration while blending the PCL, THF, and
DMF. It is also feasible to incorporate sacrificial beads into
the biofilms that will degrade, leaving an increased porosity
(e.g. use of salt particulate (NaCl) and water-soluble poly-
mer (PEG) as co-porogens [36]). Further studies should
focus on improving the pore size and the porosity of the
biofilm, as well as its biocompatibility, degradation, absorp-
tion, excretion, and mechanical properties using an in vivo
rabbit Achilles tendon repair model.
Conclusions
In this study, we proposed the use of an internal fixation
technique and novel material to enhance tendon repair.
The biofilms used had high porosity and slow degradationrates in vitro. The pore size distribution of the biofilm was
similar to that of the paratenon of rabbit Achilles tendon.
Internal fixation with the biofilm followed by standard su-
ture techniques significantly increased the tensile strength
of the tendon repair site, and thus might allow early active
motion rehabilitation without the risk of rupture. How-
ever, in vivo studies are needed to further explore whether
the biofilms will enhance the healing properties of
repaired tendons.
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